JNJ-42847922/MIN-202, a selective orexin 2 receptor antagonist, demonstrates beneficial effects on mood and sleep in patients with major depressive disorder
Author(s):
Recourt, K.; Amerongen, G. van; Jacobs, G.; Zuiker, R.; Luthringer, R.; Ark, P. van der; Gerven, J. van
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-10-31
Language
English
Is part of
European Neuropsychopharmacology (2017), Vol. 27, p. S866-S866
